JOHN F. BOHNSACK
Medical Practice at Medical Dr, Salt Lake City, UT
License number
Utah 177835-1205
Category
Medical Practice
Type
Pediatric Rheumatology
Address
Address
100 N Medical Dr, Salt Lake City, UT 84113
Phone
(801) 581-2121
(801) 213-3800
(801) 213-3800
Personal information
See more information about JOHN F. BOHNSACK at radaris.comName
Address
Phone
760 1200 E, Salt Lake City, UT 84102
S Salt Lake, UT
Professional information
See more information about JOHN F. BOHNSACK at trustoria.com
Dr. John F Bohnsack, Salt Lake City UT - MD (Doctor of Medicine)
Dr. John F Bohnsack, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Pediatric Rheumatology
Address:
University Healthcare-Pediatric
100 Mario Capecchi Dr, Salt Lake City 84113
(801) 213-3599 (Phone)
100 Mario Capecchi Dr, Salt Lake City 84113
(801) 213-3599 (Phone)
Certifications:
Pediatric Rheumatology, 2000, Pediatrics, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Virginia / Main Campus
Graduated: 1978
University Of Washington
University of Virginia / Main Campus
Graduated: 1978
University Of Washington
John F Bohnsack, Salt Lake City UT
John F Bohnsack, Salt Lake City UT
Specialties:
Pediatric Rheumatologist
Address:
100 N Medical Dr, Salt Lake City, UT 84113
50 N Medical Dr, Salt Lake City, UT 84132
50 N Medical Dr, Salt Lake City, UT 84132
Education:
University of Virginia, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Rheumatology (Pediatrics)
John Francis Bohnsack, Salt Lake City UT
John Francis Bohnsack, Salt Lake City UT
Specialties:
Pediatrics, Pediatric Rheumatology
Work:
Pcmc Immunology Dept
100 Mario Capecchi Dr, Salt Lake City, UT 84113 Uumc
50 N Medical Dr, Salt Lake City, UT 84132
100 Mario Capecchi Dr, Salt Lake City, UT 84113 Uumc
50 N Medical Dr, Salt Lake City, UT 84132
Education:
University of Virginia (1978)
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
2004007, Apr 15, 2004
Filed:
Jul 8, 2003
Appl. No.:
10/333002
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
International Classification:
A61K039/02, C07H021/04, C07K014/315, C12N001/21
US Classification:
424/190100, 530/350000, 435/069100, 435/320100, 435/252300, 536/023700
Abstract:
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including and are also provided. Antibodies to the Ema polypeptides and immunogenic fragments thereof are also provided. The present invention relates to the identification and prevention of infections by virulent forms of streptococci. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptides, antibodies thereto, and nucleic acids. Assays for compounds which modulate the polypeptides of the present invention for use in therapy are also provided.
Group B Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
Group B Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
7892552, Feb 22, 2011
Filed:
Dec 7, 2009
Appl. No.:
12/632269
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
St. Jude Children's Research Hospital - Memphis TN
St. Jude Children's Research Hospital - Memphis TN
International Classification:
A61K 39/40
US Classification:
4241651, 4242441, 5303871, 435 71, 435 732
Abstract:
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including and are also provided. Antibodies to the Ema polypeptides and immunogenic fragments thereof are also provided. The present invention relates to the identification and prevention of infections by virulent forms of streptococci. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptides, antibodies thereto, and nucleic acids. Assays for compounds which modulate the polypeptides of the present invention for use in therapy are also provided.
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
Group B Streptococcus Polypeptides Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
7645577, Jan 12, 2010
Filed:
Jul 26, 2006
Appl. No.:
11/493705
Inventors:
Elisabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
University of Utah Research Foundation - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
International Classification:
C12Q 1/68
US Classification:
435 6, 536 237, 536 2432, 4353201, 4352523
Abstract:
This invention provides isolated nucleic acids encoding polypeptides comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides. The invention provides nucleic acids encoding Group B streptococcal Ema polypeptides EmaA, EmaB, EmaC, EmaD and EmaE. The present invention provides isolated polypeptides comprising amino acid sequences of Group B streptococcal polypeptides EmaA, EmaB, EmaC, EmaD and EmaE, including analogs, variants, mutants, derivatives and fragments thereof. Ema homologous polypeptides from additional bacterial species, including and are also provided. Antibodies to the Ema polypeptides and immunogenic fragments thereof are also provided. The present invention relates to the identification and prevention of infections by virulent forms of streptococci. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptides, antibodies thereto, and nucleic acids. Assays for compounds which modulate the polypeptides of the present invention for use in therapy are also provided.
Group B Polypeptides, Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
Group B Polypeptides, Nucleic Acids And Therapeutic Compositions And Vaccines Thereof
US Patent:
8529912, Sep 10, 2013
Filed:
Feb 18, 2011
Appl. No.:
13/030660
Inventors:
Elizabeth Adderson - Memphis TN, US
John Bohnsack - Salt Lake City UT, US
John Bohnsack - Salt Lake City UT, US
Assignee:
St. Jude Children's Reseach Hospital - Memphis TN
University of Utah Research Foundation - Salt Lake City UT
University of Utah Research Foundation - Salt Lake City UT
International Classification:
C07K 14/315
US Classification:
4242441, 4241851, 4241901, 4241931, 4242031, 530350
Abstract:
This invention provides an isolated nucleic acid encoding a polypeptide comprising amino acid sequences of a streptococcal matrix adhesion E (EmaE) polypeptide. Antibodies to the EmaE polypeptide and immunogenic fragments thereof are also provided. This invention provides pharmaceutical compositions, immunogenic compositions, vaccines, and diagnostic and therapeutic methods of use of the isolated polypeptide, antibodies thereto, and nucleic acids.
Methods And Compositions For Diagnosing And Preventing A Group B Streptococcal Infection
Methods And Compositions For Diagnosing And Preventing A Group B Streptococcal Infection
US Patent:
7588773, Sep 15, 2009
Filed:
Aug 19, 2005
Appl. No.:
11/574067
Inventors:
Linda Jeannine Brady - Gainesville FL, US
Kyle N. Seifert - Harrisonburg VA, US
Elisabeth E. Adderson - Memphis TN, US
John F. Bohnsack - Salt Lake City UT, US
Kyle N. Seifert - Harrisonburg VA, US
Elisabeth E. Adderson - Memphis TN, US
John F. Bohnsack - Salt Lake City UT, US
Assignee:
St. Jude Children's Research Hospital - Memphis TN
University of Florida - Gainesville FL
University of Utah Research Foundation - Salt Lake City UT
University of Florida - Gainesville FL
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 39/09, C07K 14/315, C07H 21/04, C12P 21/04, C12N 15/00
US Classification:
4242441, 4241841, 530350, 435 697, 4353201, 536 237
Abstract:
The present invention provides a group B (GBS) surface antigen, designated epsilon antigen, that is co-expressed with the delta antigen on a subset of serotype III GBS. Epsilon is expressed on more pathogenic Restriction Digest Pattern (RDP) III-3 GBS, but not on RDP types 1, 2, or 4. Accordingly, the present invention provides compositions and methods for detecting a group B serotype III, RDP III-3 strain. Vaccines and methods of identifying agents which inhibit adhesion of a group B cell to a host cell are also provided.